Connect with us

Hi, what are you looking for?

Investing

Wegovy-Maker Novo Nordisk to Spend More Than $2 Billion Boosting Production in France

Published

By Elena Vardon

Pharmaceutical giant Novo Nordisk said it will invest more than 16 billion Danish kroner ($2.34 billion) in its French production site as it seeks to meet rising demand for its blockbuster obesity and diabetes treatments.

The Danish company, which makes the Wegovy obesity drug and diabetes drug Ozempic, said Thursday that the…

Master your money.

Subscribe to MarketWatch.

Get this article and all of MarketWatch.

Access from any device. Anywhere. Anytime.

Subscribe Now

Log In

Read the full article here

In this article:
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

News

Bristol-Myers Squibb Company 2025 Q1 – Results – Earnings Call Presentation (NYSE:BMY)

This article was written by Follow Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish...

7 days ago

Videos

Why You Are Getting So Many Fake Job Offers By Text

Watch full video on YouTube

7 days ago

Videos

Google And Meta Are Scrambling To Copy TikTok. Can They Catch up?

Watch full video on YouTube

5 days ago

News

China Untapped, Netflix Offers Risk Capital Upside While Maintaining A High Floor (NASDAQ:NFLX)

This article was written by Follow Markets rise and fall, booms come and go, and the world keeps ticking. Ultimately, I believe observing megatrends,...

5 days ago